SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2268)2/20/2008 4:29:51 PM
From: Jibacoa  Respond to of 3722
 
SPNC Is another one that was down 28.5% after reporting its 4thQ results,which continued to show improvement from 2006 results.<g>

Volume of 3,684,031 was about 17x its ADV, but the stock is trying to cut some of its loss AHs.<g>

bigcharts.marketwatch.com

Revenue for the 4thQ was $23.9M, up 35% vs. $17.7M in 2006.The loss was $89,000, ($0.00/shr) vs. $952,000,($0.03/shr) in 2006.

SPNC has 4Qs of double digit improvements on revenues & the EE for 2008 & 2009 are around $0,20 & $0.30/shr vs, the $0.02/shr in 2007.

Will see if the stock can find support above the $8 level.<g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (2268)8/6/2009 1:53:36 PM
From: Jibacoa  Respond to of 3722
 
MBRK has been clobbered today after reporting its 2ndQ results.<g>

bigcharts.marketwatch.com

It remains on a DT on its longer term chart.<g>

bigcharts.marketwatch.com

Bernard